Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Shanghai Pharmaceuticals Holding Co Ltd Class H (HK:2607)
HKEX:2607
Shanghai Pharmaceuticals Holding Co (2607) Stock Forecast & Price Target
2 Followers
See the Price Targets and Ratings of:
2607 Analyst Ratings
Moderate Buy
1 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
2607 Stock 12 Month Forecast
Average Price Target
HK$17.49
▲(48.18% Upside)
| Highest Price TargetHK$17.50 | Average Price TargetHK$17.49 | Lowest Price TargetHK$17.50 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Morgan Stanley
Reiterated
06/06/24
Goldman Sachs
HK$13.98→HK$13.44
Sell
13.90%
Upside
Reiterated
04/03/24
Shanghai Pharmaceuticals Holdings (2607:HK) (FJLLF) PT Lowered to HK$13.44 at Goldman SachsGoldman Sachs analyst Ziyi Chen lowered the price target on Shanghai Pharmaceuticals Holdings (2607:HK) (OTC: FJLLF) to HK$13.44 (from HK$13.98) while maintaining a Sell rating.
Unknown Analyst
Not Ranked
Citi
HK$19→HK$17.5
Buy
48.31%
Upside
Reiterated
11/07/23
Shanghai Pharmaceuticals Holdings (2607:HK) (FJLLF) PT Lowered to HK$17.50 at CitiCiti analyst David Shang lowered the price target on Shanghai Pharmaceuticals Holdings (2607:HK) (OTC: FJLLF) to HK$17.50 (from HK$19.00) while maintaining a Buy rating.
Unknown Analyst
Not Ranked
CLSA
HK$15.5→HK$13.54
Buy
14.75%
Upside
Reiterated
03/31/24
Shanghai Pharmaceuticals Holdings (2607:HK) (FJLLF) PT Lowered to HK$13.54 at CLSACLSA analyst John Yung lowered the price target on Shanghai Pharmaceuticals Holdings (2607:HK) (OTC: FJLLF) to HK$13.54 (from HK$15.50) while maintaining a Buy (1) rating.
Best Analysts Covering Shanghai Pharmaceuticals Holding Co
Which Analyst Should I Follow If I Want to Buy HK:2607 and Sell After:
1 Month
3 Months
1 Year
Success Rate
1/2 ratings generated profit
Average Return
+4.95%
reiterated a buy rating last month
Copying Laurence Tam's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +4.95% per trade.
2 Years
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
2607 Analyst Recommendation Trends
Rating
Oct 23
Nov 23
Dec 23
Apr 24
Jun 24
Strong Buy
0
1
2
2
2
Buy
0
0
0
0
0
Hold
1
1
0
0
0
Sell
1
1
1
1
1
Strong Sell
0
0
0
0
0
total
2
3
3
3
3
Each month's total comprises the sum of three months' worth of ratings.
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
2607 Financial Forecast
2607 Stock Forecast FAQ
What is HK:2607’s average 12-month price target, according to analysts?
Based on analyst ratings, Shanghai Pharmaceuticals Holding Co Ltd Class H’s 12-month average price target is HK$17.49.
What is HK:2607’s upside potential, based on the analysts’ average price target?
Shanghai Pharmaceuticals Holding Co Ltd Class H has 48.18% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Shanghai Pharmaceuticals Holding Co Ltd Class H a Buy, Sell or Hold?
Shanghai Pharmaceuticals Holding Co Ltd Class H has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Shanghai Pharmaceuticals Holding Co Ltd Class H’s share price target?
The average share price target for Shanghai Pharmaceuticals Holding Co Ltd Class H is HK$17.49. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is HK$17.50 ,and the lowest forecast is HK$17.50. The average share price target represents 48.18% Increase from the current price of HK$11.8.
The highest analyst share price target is HK$17.50 ,and the lowest forecast is HK$17.50. The average share price target represents 48.18% Increase from the current price of HK$11.8.
What do analysts say about Shanghai Pharmaceuticals Holding Co Ltd Class H?
Shanghai Pharmaceuticals Holding Co Ltd Class H’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
How can I buy shares of Shanghai Pharmaceuticals Holding Co Ltd Class H?
To buy shares of HK:2607, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.